Clinical Cancer Research, Vol 2, Issue 9 1601-1606, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion

C Noviello, F Courjal and C Theillet
Institut de Genetique Moleculaire de Montpellier, UMR CNRS 9942, 1919 route de Mende, 34033 Montpellier Cedex 1, France.

Deletions and rearrangements involving chromosome 6q have been reported in a number of human cancers such as ovarian and breast tumors as well as melanoma and hemopoietic malignancies. To gain insight into the regions undergoing deletions on the long arm of chromosome 6, we performed a survey of loss of heterozygosity (LOH) at 11 CA repeat markers, mapping from 6q13 to 6q27 in 83 matched sets of tumor and blood DNAs from breast tumor patients. LOH was observed at all tested markers with frequencies ranging from 11.4 to 39.8% of the informative cases, whereas D2S123, a marker linked to the HMSH2 gene mapping in a region rarely presenting allele losses, showed 3.2%. LOH patterns were often complex, with a number of tumors presenting multiple interstitial losses, thus indicating that chromosome 6q can be severely rearranged in breast cancer. Patterns of losses and correlation between LOH occurring at adjacent markers suggested the existence of three (possibly four) distinct regions of allele losses. These were defined by: D6S251-D6S434 (6q13), D6S292-D6S310-D6S314-D6S311 (6q24-q25), and D6S441-D6S281 (6q27). The fourth and more hypothetical region was in the 6q21 region and defined by D6S287-D6S407. Interestingly, the region at 6q24-q25 defined by D6S292-D6S310-D6S314-D6S311 was predominantly observed in evolved and aggressive breast tumors. LOH at D6S314 was correlated with PR- tumors. All together, our data suggest the possible presence of several genes on 6q whose alteration may play a role in breast cancer formation and development.

This article has been cited by other articles:

				Y. Wang, Y. Liu, C. Wu, B. McNally, Y. Liu, and P. Zheng Laforin Confers Cancer Resistance to Energy Deprivation-Induced Apoptosis Cancer Res., June 1, 2008; 68(11): 4039 - 4044. [Abstract] [Full Text] [PDF]

				K. A. Callaghan, T. E. Becker, D. L. Ellsworth, J. A. Hooke, R. E. Ellsworth, and C. D. Shriver Genomic Instability and the Development of Metastatic Lymph Node Tumors Ann. Surg. Oncol., November 1, 2007; 14(11): 3125 - 3132. [Abstract] [Full Text] [PDF]

				Y. Takahashi, Y. Miyoshi, C. Takahata, N. Irahara, T. Taguchi, Y. Tamaki, and S. Noguchi Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers Clin. Cancer Res., February 15, 2005; 11(4): 1380 - 1385. [Abstract] [Full Text] [PDF]

				E. C. Burton, K. R. Lamborn, B. G. Feuerstein, M. Prados, J. Scott, P. Forsyth, S. Passe, R. B. Jenkins, and K. D. Aldape Genetic Aberrations Defined by Comparative Genomic Hybridization Distinguish Long-Term from Typical Survivors of Glioblastoma Cancer Res., November 1, 2002; 62(21): 6205 - 6210. [Abstract] [Full Text] [PDF]

				M. Inoue, A. Marx, A. Zettl, P. Strobel, H.-K. Muller-Hermelink, and P. Starostik Chromosome 6 Suffers Frequent and Multiple Aberrations in Thymoma Am. J. Pathol., October 1, 2002; 161(4): 1507 - 1513. [Abstract] [Full Text] [PDF]

				D. Roy, G. Calaf, and T. K. Hei Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells Carcinogenesis, October 1, 2001; 22(10): 1685 - 1692. [Abstract] [Full Text] [PDF]

				G. An, A. Y. Ng, C. S. R. Meka, G. Luo, S. P. Bright, L. Cazares, G. L. Wright Jr., and R. W. Veltri Cloning and Characterization of UROC28, a Novel Gene Overexpressed in Prostate, Breast, and Bladder Cancers Cancer Res., December 1, 2000; 60(24): 7014 - 7020. [Abstract] [Full Text]

				G. Piras, A. El Kharroubi, S. Kozlov, D. Escalante-Alcalde, L. Hernandez, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and C. L. Stewart Zac1 (Lot1), a Potential Tumor Suppressor Gene, and the Gene for varepsilon -Sarcoglycan Are Maternally Imprinted Genes: Identification by a Subtractive Screen of Novel Uniparental Fibroblast Lines Mol. Cell. Biol., May 1, 2000; 20(9): 3308 - 3315. [Abstract] [Full Text]

				M. G. Tibiletti, F. Sessa, B. Bernasconi, R. Cerutti, B. Broggi, D. Furlan, F. Acquati, M. Bianchi, A. Russo, C. Capella, et al. A Large 6q Deletion Is a Common Cytogenetic Alteration in Fibroadenomas, Pre-malignant Lesions, and Carcinomas of the Breast Clin. Cancer Res., April 1, 2000; 6(4): 1422 - 1431. [Abstract] [Full Text]

				L. D. Attardi, E. E. Reczek, C. Cosmas, E. G. Demicco, M. E. McCurrach, S. W. Lowe, and T. Jacks PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family Genes & Dev., March 15, 2000; 14(6): 704 - 718. [Abstract] [Full Text]

				K. Hishikawa, B. S. Oemar, F. C. Tanner, T. Nakaki, T. F. Luscher, and T. Fujii Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7 J. Biol. Chem., December 24, 1999; 274(52): 37461 - 37466. [Abstract] [Full Text] [PDF]

				J. M. Silva, G. Dominguez, J. M. Garcia, R. Gonzalez, M. J. Villanueva, F. Navarro, M. Provencio, S. San Martin, P. Espana, and F. Bonilla Presence of Tumor DNA in Plasma of Breast Cancer Patients: Clinicopathological Correlations Cancer Res., July 1, 1999; 59(13): 3251 - 3256. [Abstract] [Full Text] [PDF]

				A. Varrault, E. Ciani, F. Apiou, B. Bilanges, A. Hoffmann, C. Pantaloni, J. Bockaert, D. Spengler, and L. Journot hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer PNAS, July 21, 1998; 95(15): 8835 - 8840. [Abstract] [Full Text] [PDF]